Mara Parellada Selected Research

Mara Parellada Research Topics

Disease

55	Psychotic Disorders (Schizoaffective Disorder) 01/2024 - 11/2004
25	Schizophrenia (Dementia Praecox) 11/2023 - 10/2007
8	Autism Spectrum Disorder 10/2023 - 01/2017
5	Weight Gain 01/2021 - 03/2010
4	Cognitive Dysfunction 01/2023 - 05/2015
4	Bipolar Disorder (Manic Depressive Psychosis) 01/2016 - 03/2010
3	Autistic Disorder (Autism) 01/2023 - 11/2014
3	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2023 - 07/2014
3	Neurodevelopmental Disorders 01/2022 - 12/2019
3	Body Weight (Weight, Body) 01/2021 - 08/2011
3	Psychotic Affective Disorders 03/2016 - 06/2014
2	Epilepsy (Aura) 01/2023 - 01/2023
2	Cerebral Cortical Thinning 11/2022 - 01/2019
2	Inflammation (Inflammations) 08/2015 - 02/2013
1	Polyuria 10/2023
1	Hypokalemia 10/2023
1	Hyperphagia (Overeating) 01/2023
1	Prader-Willi Syndrome (Syndrome, Prader-Willi) 01/2023
1	Neurobehavioral Manifestations 10/2022
1	Disease Progression 01/2022
1	Infections 01/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021
1	Dyslipidemias (Dyslipidemia) 01/2021
1	Hyperglycemia 01/2021
1	Obesity 01/2020
1	Abdominal Obesity 01/2020
1	Atrophy 01/2020
1	Metabolic Diseases (Metabolic Disease) 01/2020
1	Neoplasms (Cancer) 01/2019
1	Drug-Related Side Effects and Adverse Reactions 04/2016
1	Hallucinations (Hallucination) 04/2015
1	Insulin Resistance 11/2014
1	Major Depressive Disorder (Major Depressive Disorders) 07/2014
1	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 07/2014
1	Anxiety Disorders (Anxiety Disorder) 07/2014
1	Neuroinflammatory Diseases 02/2013
1	Encephalitis (Encephalitis, Rasmussen) 02/2013
1	Necrosis 02/2013

Drug/Important Bio-Agent (IBA)

34	Polytetrafluoroethylene (Teflon)FDA Link 01/2024 - 11/2008
16	Antipsychotic Agents (Antipsychotics)IBA 01/2023 - 11/2004
9	Silver Sulfadiazine (SSD)FDA LinkGeneric 01/2023 - 01/2011
8	Biomarkers (Surrogate Marker)IBA 01/2023 - 02/2011
5	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2022 - 01/2016
5	AntioxidantsIBA 01/2018 - 02/2011
5	Olanzapine (Zyprexa)FDA Link 11/2014 - 12/2008
5	Quetiapine Fumarate (Seroquel)FDA Link 11/2014 - 12/2008
4	Glutathione (Reduced Glutathione)IBA 06/2014 - 02/2011
3	Oxytocin (Pitocin)FDA LinkGeneric 11/2023 - 01/2022
3	ProlactinIBA 11/2023 - 08/2011
3	Bumetanide (Bumex)FDA LinkGeneric 10/2023 - 08/2021
3	Nerve Growth Factors (Neurotrophins)IBA 07/2022 - 01/2022
3	Triglycerides (Triacylglycerol)IBA 01/2021 - 11/2014
3	LDL CholesterolIBA 01/2021 - 03/2010
3	CholesterolIBA 01/2021 - 03/2010
3	Risperidone (Risperdal Consta)FDA LinkGeneric 11/2014 - 08/2011
2	HomocysteineIBA 11/2023 - 03/2012
2	Cholinergic Antagonists (Anticholinergics)IBA 10/2022 - 04/2016
2	N 30IBA 01/2022 - 03/2010
2	Indicators and Reagents (Reagents)IBA 01/2019 - 07/2006
2	Clozapine (Clozaril)FDA LinkGeneric 04/2016 - 08/2011
2	Antidepressive Agents (Antidepressants)IBA 04/2016 - 07/2014
2	EndocannabinoidsIBA 04/2016 - 12/2013
1	SolutionsIBA 10/2023
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2023
1	4- (3,4- dichlorophenyl)- 1,2,3,4- tetrahydronaphthalen- 1- amineIBA 01/2023
1	carbetocinIBA 01/2023
1	MicroRNAs (MicroRNA)IBA 01/2023
1	Nerve Growth Factor (NGF)IBA 01/2022
1	Glutamate Receptors (Glutamate Receptor)IBA 01/2022
1	Sp4 Transcription FactorIBA 01/2022
1	Aminobutyrates (Aminobutyric Acid)IBA 01/2020
1	HDL CholesterolIBA 01/2020
1	AMPA Receptors (AMPA Receptor)IBA 12/2019
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	NucleotidesIBA 01/2018
1	Serotonin (5 Hydroxytryptamine)IBA 11/2017
1	TeaIBA 01/2017
1	BenzodiazepinesIBA 04/2016
1	ChromatinIBA 11/2014
1	Glucose (Dextrose)FDA LinkGeneric 11/2014
1	Insulin (Novolin)FDA Link 11/2014
1	Genetic Markers (Genetic Marker)IBA 03/2014
1	15-deoxyprostaglandin J2IBA 03/2014
1	Transcription Factors (Transcription Factor)IBA 02/2013
1	EnzymesIBA 02/2013
1	InterleukinsIBA 02/2013
1	LipopolysaccharidesIBA 02/2013
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 02/2013
1	CytokinesIBA 02/2013
1	Nitric Oxide Synthase (NO Synthase)IBA 02/2013
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 02/2013
1	p38 Mitogen-Activated Protein KinasesIBA 02/2013
1	CopperIBA 03/2012

Therapy/Procedure

1	Length of Stay 10/2022
1	Continuity of Patient Care 01/2022
1	Secondary Prevention 01/2022
1	Drug Therapy (Chemotherapy) 01/2020
1	Therapeutics 01/2019
1	Injections 04/2016